Table 1. Comparison of scientific innovation and biotechnology development between Brazil, Argentina, Chile, United Kingdom and United States of America.

BRAZIL

ARGENTINA

CHILE

UK

USA

Population millions (2002)

175.09

38.0

15.6 c

58.8 e

282.1 h

No of biotechnology companies (2002)

350 b

250 a

31 d

550 f

1,457 i

Nº of companies / population (106)

2

6.6

2

9.3

5.16

Total revenues of biotechnology industry
(In US$ million, 2002)

7,000 b

75 a

10

4,700 f

28,500 i

Total revenue (106) / Nº of companies

20

0.3

0.32

8.5

20

No of biological researchers (2000)

20,233

9,587

1,860

47,000 g

446,890

Nº of companies / Nº of biological researchers (103)

17

26

17

12

3.2

% of GDP invested in Research and Development (2000)

1.05

0.44

0.56

1.83 g

2.68

No of scientific publications identified via Medline (2000)

4,021

1,466

555

27,931

146,622

Total No of patent applications
(including residents + non residents, 2000)

19,325

6,633

3,683

21,580 j

295,000

Total No of granted patents
(including residents + non residents, 2000)

9,269

1,587

620

2,962 j

157,495

Nº of granted patents / Nº of patent applications

0.48

0.24

0.17

0.14

0.53


Sources: Iberoamerican Network of Science and Technology Indicators

a: The biotechnology market in Argentina, 2003 ;
b: The biotechnology market in Brazil, 2002;
c: National statistics Bureau, Chile;
d: National Commission for the Development of Biotechnology, Chile;
e: 10 Downing street website, UK Population 2001;
f: BioIndustry Association, UK;
g: UK Research and Development website;
h: U.S. Census Bureau ;
i: Biotechnology Industry Organization;
j: UK patent office.


Supported by UNESCO / MIRCEN network